These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8493423)

  • 1. Data monitoring committees for Southwest Oncology Group clinical trials.
    Green S; Crowley J
    Stat Med; 1993 Mar; 12(5-6):451-5. PubMed ID: 8493423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What is the appropriate role of the trial statistician in preparing and presenting interim findings to an independent Data Monitoring Committee in the U.S. Cancer Cooperative Group setting?
    Bryant J
    Stat Med; 2004 May; 23(10):1507-11. PubMed ID: 15122728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A survey of monitoring practices in cancer clinical trials.
    George SL
    Stat Med; 1993 Mar; 12(5-6):435-50. PubMed ID: 8493422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The independent statistician for data monitoring committees.
    DeMets DL; Fleming TR
    Stat Med; 2004 May; 23(10):1513-7. PubMed ID: 15122729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of independent data-monitoring committees in randomized clinical trials sponsored by the National Cancer Institute.
    Smith MA; Ungerleider RS; Korn EL; Rubinstein L; Simon R
    J Clin Oncol; 1997 Jul; 15(7):2736-43. PubMed ID: 9215848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of external monitoring committees in clinical trials of the National Institute of Allergy and Infectious Diseases.
    Ellenberg SS; Myers MW; Blackwelder WC; Hoth DF
    Stat Med; 1993 Mar; 12(5-6):461-7; discussion 469. PubMed ID: 8493424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practical issues in data monitoring of clinical trials: summary of responses to a questionnaire at NIH.
    Geller NL; Stylianou M
    Stat Med; 1993 Mar; 12(5-6):543-51; discussion 553. PubMed ID: 8493430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical trial monitoring: hit or miss?
    Cohen J
    Science; 1994 Jun; 264(5165):1534-7. PubMed ID: 8202707
    [No Abstract]   [Full Text] [Related]  

  • 9. Data Monitoring Committees and early stopping guidelines: the Southwest Oncology Group experience.
    Crowley J; Green S; Liu PY; Wolf M
    Stat Med; 1994 Jul 15-30; 13(13-14):1391-9. PubMed ID: 7973218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring clinical trials: experience of, and proposals under consideration by, the Cancer Therapy Committee of the British Medical Research Council.
    Parmar MK; Machin D
    Stat Med; 1993 Mar; 12(5-6):497-504. PubMed ID: 8493427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Data monitoring committees for multicenter clinical trials sponsored by the National Institutes of Health. I. Roles and membership of data monitoring committees for trials sponsored by the National Eye Institute.
    Hawkins BS
    Control Clin Trials; 1991 Jun; 12(3):424-37. PubMed ID: 1651212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Data monitoring boards in the pharmaceutical industry.
    Herson J
    Stat Med; 1993 Mar; 12(5-6):555-61; discussion 563. PubMed ID: 8493431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of therapeutic research on informed consent and the ethics of clinical trials: a medical oncology perspective.
    Daugherty CK
    J Clin Oncol; 1999 May; 17(5):1601-17. PubMed ID: 10334550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The NHLBI model: a 25 year history.
    Friedman L
    Stat Med; 1993 Mar; 12(5-6):425-31. PubMed ID: 8493421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Data monitoring committees and capturing relevant information of high quality.
    Fleming TR
    Stat Med; 1993 Mar; 12(5-6):565-70; discussion 571-3. PubMed ID: 8493432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some practical aspects of the interim monitoring of clinical trials.
    Simon R
    Stat Med; 1994 Jul 15-30; 13(13-14):1401-9. PubMed ID: 7973219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NIH orders Duke Medical Center to stop studies.
    Ann Oncol; 1999 Jul; 10(7):739. PubMed ID: 10470415
    [No Abstract]   [Full Text] [Related]  

  • 18. Stopping rules, interim analyses and data monitoring committees.
    Ashby D; Machin D
    Br J Cancer; 1993 Dec; 68(6):1047-50. PubMed ID: 8260354
    [No Abstract]   [Full Text] [Related]  

  • 19. Guidelines for data and safety monitoring for clinical trials not requiring traditional data monitoring committees.
    ; Dixon DO; Freedman RS; Herson J; Hughes M; Kim K; Silverman MH; Tangen CM
    Clin Trials; 2006; 3(3):314-9. PubMed ID: 16895048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A major trial needs three statisticians: why, how and who?
    Pocock SJ
    Stat Med; 2004 May; 23(10):1535-9. PubMed ID: 15122734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.